Literature DB >> 27567871

Stroke, Vascular Dementia, and Alzheimer's Disease: Molecular Links.

Murali Vijayan1, P Hemachandra Reddy1,2,3,4,5,6.   

Abstract

Stroke is a brain disease that occurs when blood flow stops, resulting in reduced oxygen supply to neurons. Stroke occurs at any time and at any age, but increases after the age of 55. It is the second leading cause of death and the third leading cause of disability-adjusted, life-years. The pathophysiology of ischemic stroke is complex and recent molecular, cellular, and animal models and postmortem brain studies have revealed that multiple cellular changes have been implicated, including oxidative stress/mitochondrial dysfunction, inflammatory responses, micro RNA alterations, and marked changes in brain proteins. These cellular changes provide new information for developing therapeutic strategies for ischemic stroke treatment. Research also revealed that stroke increases with a number of modifiable factors and most strokes can be prevented and/or controlled through pharmacological or surgical interventions and lifestyle changes. Ischemic stroke is the major risk factor for vascular dementia and Alzheimer's disease. This review summarizes the latest research findings on stroke, including causal factors and molecular links between stroke and vascular disease/Alzheimer's disease.

Entities:  

Keywords:  Alzheimer’s disease; hemorrhage; inflammatory responses; ischemic stroke; magnetic resonance imaging; vascular dementia

Mesh:

Substances:

Year:  2016        PMID: 27567871      PMCID: PMC5793908          DOI: 10.3233/JAD-160527

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  123 in total

1.  Midlife blood pressure and dementia: the Honolulu-Asia aging study.

Authors:  L J Launer; G W Ross; H Petrovitch; K Masaki; D Foley; L R White; R J Havlik
Journal:  Neurobiol Aging       Date:  2000 Jan-Feb       Impact factor: 4.673

2.  Cerebrovascular protection as a possible mechanism for the protective effects of NXY-059 in preclinical models: an in vitro study.

Authors:  Maxime Culot; Caroline Mysiorek; Mila Renftel; Benoit D Roussel; Yannick Hommet; Denis Vivien; Roméo Cecchelli; Laurence Fenart; Vincent Berezowski; Marie-Pierre Dehouck; Stefan Lundquist
Journal:  Brain Res       Date:  2009-07-23       Impact factor: 3.252

3.  Middle cerebral artery occlusion in the rat by intraluminal suture. Neurological and pathological evaluation of an improved model.

Authors:  L Belayev; O F Alonso; R Busto; W Zhao; M D Ginsberg
Journal:  Stroke       Date:  1996-09       Impact factor: 7.914

4.  Mild cognitive impairments predict dementia in nondemented elderly patients with memory loss.

Authors:  A Bozoki; B Giordani; J L Heidebrink; S Berent; N L Foster
Journal:  Arch Neurol       Date:  2001-03

5.  Preexisting dementia in stroke patients. Baseline frequency, associated factors, and outcome.

Authors:  H Hénon; F Pasquier; I Durieu; O Godefroy; C Lucas; F Lebert; D Leys
Journal:  Stroke       Date:  1997-12       Impact factor: 7.914

6.  Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition.

Authors:  Z Chen; A C Karaplis; S L Ackerman; I P Pogribny; S Melnyk; S Lussier-Cacan; M F Chen; A Pai; S W John; R S Smith; T Bottiglieri; P Bagley; J Selhub; M A Rudnicki; S J James; R Rozen
Journal:  Hum Mol Genet       Date:  2001-03-01       Impact factor: 6.150

7.  Deficiency of acyl CoA:cholesterol acyltransferase 2 prevents atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Emily L Willner; Bryan Tow; Kimberly K Buhman; Martha Wilson; David A Sanan; Lawrence L Rudel; Robert V Farese
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-21       Impact factor: 11.205

8.  [The protective effects of melatonin on global cerebral ischemia-reperfusion injury in gerbils].

Authors:  Jing Zhang; Ji-dong Guo; Shu-hua Xing; Shu-ling Gu; Ti-jun Dai
Journal:  Yao Xue Xue Bao       Date:  2002-05

9.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

10.  Tryptophan is a marker of human postmortem brain tissue quality.

Authors:  Edna Grünblatt; Camelia Maria Monoranu; Manuela Apfelbacher; Daniela Keller; Tanja M Michel; Irina Alafuzoff; Isidro Ferrer; Safa Al-Saraj; Kathy Keyvani; Andrea Schmitt; Peter Falkai; Jens Schittenhelm; Catriona McLean; Glenda M Halliday; Clive Harper; Jürgen Deckert; Wolfgang Roggendorf; Peter Riederer
Journal:  J Neurochem       Date:  2009-06-22       Impact factor: 5.372

View more
  59 in total

1.  A Critical Assessment of Research on Neurotransmitters in Alzheimer's Disease.

Authors:  P Hemachandra Reddy
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

2.  Nanomaterial based drug delivery systems for the treatment of neurodegenerative diseases.

Authors:  Shima Masoudi Asil; Jyoti Ahlawat; Gileydis Guillama Barroso; Mahesh Narayan
Journal:  Biomater Sci       Date:  2020-07-08       Impact factor: 6.843

Review 3.  Alzheimer's Disease in the Latino Community: Intersection of Genetics and Social Determinants of Health.

Authors:  Irving E Vega; Laura Y Cabrera; Cassandra M Wygant; Daniel Velez-Ortiz; Scott E Counts
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 4.  Current advances in ischemic stroke research and therapies.

Authors:  Derek Barthels; Hiranmoy Das
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-09-15       Impact factor: 5.187

Review 5.  Neurodegenerative diseases have genetic hallmarks of autoinflammatory disease.

Authors:  Robert I Richards; Sarah A Robertson; Daniel L Kastner
Journal:  Hum Mol Genet       Date:  2018-08-01       Impact factor: 6.150

Review 6.  Mitochondrial dysfunction and oxidative stress in metabolic disorders - A step towards mitochondria based therapeutic strategies.

Authors:  Jasvinder Singh Bhatti; Gurjit Kaur Bhatti; P Hemachandra Reddy
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2016-11-09       Impact factor: 5.187

7.  Elevated Risk of Cognitive Impairment Among Older Sexual Minorities: Do Health Conditions, Health Behaviors, and Social Connections Matter?

Authors:  Ning Hsieh; Hui Liu; Wen-Hua Lai
Journal:  Gerontologist       Date:  2021-04-03

Review 8.  Nanomaterial-based blood-brain-barrier (BBB) crossing strategies.

Authors:  Jinbing Xie; Zheyu Shen; Yasutaka Anraku; Kazunori Kataoka; Xiaoyuan Chen
Journal:  Biomaterials       Date:  2019-09-14       Impact factor: 12.479

9.  Comorbidity patterns among people living with HIV: a hierarchical clustering approach through integrated electronic health records data in South Carolina.

Authors:  Xueying Yang; Jiajia Zhang; Shujie Chen; Sharon Weissman; Bankole Olatosi; Xiaoming Li
Journal:  AIDS Care       Date:  2020-11-10

Review 10.  Protein Aggregation in the Pathogenesis of Ischemic Stroke.

Authors:  Shusheng Wu; Longfei Du
Journal:  Cell Mol Neurobiol       Date:  2020-06-11       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.